|
Current Status:
|
|
Chief of Staff, Bakersfield Heart Hospital, 1998-present
|
|
Director of Cardiac Services, Bakersfield Memorial Hospital, 1998-present
|
|
Medical Director of Cardiology Services, Mercy Westside Hospital, 1997-present
|
|
Cardiologist, Central Cardiology Medical Clinic, 1988-present
|
|
Director of Echocardiography Laboratory, Memorial Hospital, 1999-1996
|
|
Director of Cardiac Cath Laboratory, Memorial Hospital, 1989-1996
|
|
Vice-Chairman, Department of Medicine, Memorial Hospital, 1993-1994
|
|
Chairman, Department of Medicine, Memorial Hospital, 1994-1996
|
|
Regional Counselor, California Chapter, American College of Cardiology,
1993-1998
|
|
Committee Member, California Chapter, American College of Cardiology,
1993-present
|
|
|
Specialty Certification:
|
|
Board Certification:National Board of Medical Examiners, completed 1982
|
|
American Board of Internal Medicine, 1984
|
|
American Board of Internal Medicine Subspecialty Board of Cardiology, 1987
|
|
|
Academic Appointments:
|
|
Assistant Clinical Professor of Medicine, University of California, Los
Angeles, California, 1990-present
|
|
Staff Physician, Ann Arbor VA Medical Center, 1987 - 88
|
|
Lecturer, Department of Internal Medicine, Division of Cardiology, University
of Michigan Medical Center, 1987 - 1988
|
|
Assistant Clinical Professor, Department of Internal Medicine, Ohio State
University Hospital, 1984 - 1985
|
|
|
Certification and Licensure:
|
|
American Board Internal Medicine, 1984
|
|
Diplomate Cardiology, American Board Internal, 1987
|
|
California Physician, 1988
|
|
Michigan Physician, 1988
|
|
|
Education:
|
|
1973-77
Bachelor of Science (Honors)
State University of New York
Stony Brook, New York
|
|
1977-81
Doctor of Medicine
New York University School of Medicine
New York, New York
|
|
|
Postgraduate Training:
|
|
1981-1982
Internship:
Ohio State University Hospital
|
|
1982-1984
Residency:
Ohio State University Hospital
|
|
1985-1988
Fellowship:
Cardiology, University of Michigan Medical Center
|
|
Professional Memberships:
|
|
American Medical Association
|
|
American College of Physicians
|
|
Fellow, American College of Cardiology
|
|
|
Publications:
|
|
Sharma S, Makkar RR, Bhambi B, Nyitray W, Desai K, Ishimori T. Intragraft
administration of abciximab and verapamil combined with direct stenting
prevents slow-flow and no-reflow phenomena in saphenous vein graft percutaneous
coronary interventions. Catheter Cardiovasc Interv 2005; 65 B:119.B 43
(abstract).
|
|
Sharma S, Lardizabal J, Nyitray W, Florence M, File C, Roland M. Mitral
Regurgitation Is A Prevalent Phenomenon In Patients With "lone" Atrial
Afibrillation And May Be A Risk Factor For Causing "lone" Atrial Fibrillation.
(submitted).
|
|
Sharma S, Nyitray W, Bhambi B.Glycoprotein IIb/IIIa inhibition in percutaneous
coronary interventions. JAMA. 2003; 290:1451.
|
|
Sharma S, Bhambi B, Nyitray W, Desai K, Davis D, Sharma G, Shukla P, File C,
Ishimori T. Bivalirudin (Angiomax) use during intracoronary brachytherapy may
predispose to acute closure. J Cardiovasc Pharmacol Ther 2003; 8:9-15.
|
|
Sharma S, Bhambi B, Nyitray W. Sirolimus-eluting coronary stents. N Engl J Med
2002; 347: 1285.
|
|
Sharma S, Nyitray W, Bhambi B. Brachytherapy and saphenous vein grafts. N Engl
J Med 2002; 347: 692.
|
|
Sharma S, Bhambi B, Nyitray W, Desai K, Sharma G, Shukla P, Antonescu A, Denny
E, Richardson K, Sadberry R, Ishimori T. Intragraft administration of abciximab
and verapamil combined with direct stenting prevents slow-flow during saphenous
vein graft percutaneous coronary interventions. Am J Cardiol 2002; 154 H.
|
|
Sharma S, Bhambi B, Nyitray W, Sharma G, Shambaugh S, Antonescu A, Shukla P,
Denny E. Delayed profound thrombocytopenia presenting 7 days after use of
abciximab (ReoPro). J Cardiovasc Pharmacol Ther 2002; 7(1):21-24.
|
|
Preparation and reactions of 2,2 - BIS (Carbetoxy)
Propyl-Cyclo-pentadienyl-dicarbonyliron. J. of Organometallic Chemistry.
236(1982), 257-266.
|
|
Nalos PC, Ismail Y, Pappas JM, Nyitray W, Don Michael TA. Intravenous
amiodarone for short-term treatment of refractory ventricular tachycardia or
fibrillation. Am Heart J 1991;122:1629.
|
|
Nalos PC, Pappas JM, Nyitray W, Ishimori T, Don Michael TA. Prospective
Community Evaluation of the Signal-Averaged Electrocardiogram in Predicting
Malignant Ventricular Arrhythmias: Beneficial Outcome with Electrophysiology
Guided Therapy. Clin Cardiol 14, 1991;970
|
|
|
Abstracts:
|
|
The Accuracy of Doppler Echocardiography in Assessing the Results of Aortic
Valvuloplasty. Clinical Research, Vol. 36, No. 3, 1988, 305A
|
|
|
Personal:
|
|
Doctor Nyitray enjoys travel and tropical ocean activities. He and his wife are
avid scuba divers. Dr. Nyitray is also a skilled underwater photographer.
|
|
|
DISCLAIMER: This web site and information is provided for general information
only and is not a substitute for professional medical advice. We are not
responsible or liable for any diagnosis or action made by a user based on the
content of this web site. |
© 2004 Central Cardiology Medical Clinic. All Rights Reserved. |